IGF1 and cancer: Indeed, it is feasible that cancer stroma may be a major underscored source of circulating IGF-I in those patients with parallel increased cancer risk and that such pools of IGF-I do not correlate with the physiological source of circulating IGF-I, which is mostly produced in the liver and may not change significantly during malignancies affecting other organs or body districts.